In-Depth Insights into the Autism Spectrum Disorder Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the autism spectrum disorder diagnostics market?
The autism spectrum disorder diagnostics market has experienced significant growth in recent years. It will grow from $27.39 billion in 2024 to $29.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. The growth is attributed to greater awareness and recognition of ASD, expanded diagnostic criteria, advancements in diagnostic tools, improvements in healthcare systems, and public health campaigns.
What will be the autism spectrum disorder diagnostics market size in the future?
The autism spectrum disorder diagnostics market is projected to grow significantly, reaching $38.94 billion by 2029, with a CAGR of 7.2%. The growth is driven by the increasing prevalence of autism spectrum disorder, awareness campaigns, and early screening. Trends include innovations in diagnostic technologies, focus on adult diagnosis, point-of-care testing, and AI and machine learning integration.
Get your autism spectrum disorder diagnostics market report here!
What main drivers are fueling expansion in the autism spectrum disorder diagnostics market?
The growth of specialized diagnostic centers is expected to stimulate the autism spectrum disorder (ASD) diagnostic market. These centers specialize in diagnosing ASD through comprehensive assessments and advanced tools. The increase in such centers is driven by technological advancements, greater awareness of autism, and professional training. For example, Autism Speaks reported that the number of autism care network sites in North America grew from 20 to 25 between 2021 and 2022. Thus, the growth of specialized diagnostic centers is fueling the ASD diagnostic market.
What key areas define the segmentation of the global autism spectrum disorder diagnostics market?
The autism spectrum disorder diagnostics market covered in this report is segmented –
1) By Type: Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder (PDD), Other Types
2) By Service: Behavioral Approaches, Early Intervention, Medication, Other Services
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Autistic Disorder: Classic Autism, Severe Autism, Mild Autism
2) By Asperger Syndrome: High Functioning Asperger Syndrome, Low Functioning Asperger Syndrome
3) By Pervasive Developmental Disorder (PDD): PDD-NOS, Childhood Disintegrative Disorder: Rett Syndrome
4) By Other Types: Childhood Autism Spectrum Disorder, Atypical Autism, Other Related Developmental Disorders
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp
Who are the dominant players expanding their reach in the autism spectrum disorder diagnostics market?
Major companies operating in the autism spectrum disorder diagnostics market are F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Siemens Healthineers, Quest Diagnostics Incorporated, Agilent Technologies Inc., Otsuka Pharmaceutical Co. Ltd., ARUP Laboratories, Invitae Corporation, Ambry Genetics, Cortica Inc., GeneDx, Cognoa Inc., Axial Therapeutics Inc., Curemark, EarliTec Diagnostics Inc., Yamo Pharmaceuticals
How are evolving market trends shaping autism spectrum disorder diagnostics Strategies?
Companies in the autism spectrum disorder (ASD) diagnostics market are developing advanced solutions using Dynamic Quantification of Social-Visual Engagement (DQSVE) to gain a competitive edge. This technology captures and analyzes children’s looking behavior at a rate of 120 times per second. For example, in September 2023, Marcus Autism Center, a US-based nonprofit healthcare organization, introduced the EarliPoint™ Evaluation, a pioneering FDA-authorized device for early ASD diagnosis in children aged 16 to 30 months. The device uses eye-tracking technology to assess social interactions and significantly reduces diagnostic time from hours to about 12 minutes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16593
Which regions are emerging as leaders in the autism spectrum disorder diagnostics market?
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2024. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024
Spectrum Analyzers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/spectrum-analyzers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
